Suppr超能文献

p53和pRb通过介导可逆的G1期阻滞来防止细胞对微管抑制剂产生再复制反应。

p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest.

作者信息

Khan S H, Wahl G M

机构信息

Department of Biology, University of California at San Diego, La Jolla 92037, USA.

出版信息

Cancer Res. 1998 Feb 1;58(3):396-401.

PMID:9458079
Abstract

Cell cycle checkpoints are safeguards that ensure the initiation of downstream events only after completion of upstream processes. The tumor suppressors p53 and pRb prevent initiation of a second round of replication in response to spindle inhibitors, but it has yet to be proven that this is a mitotic checkpoint response. We show that asynchronous human fibroblasts arrest in G1 with 4 N DNA content after nocodazole treatment, whereas isogenic p53- and pRb-deficient fibroblasts rereplicate. Importantly, nocodazole elicits a reversible arrest in G0-G1 synchronized normal human fibroblasts but not in isogenic p53-deficient derivatives. Furthermore, the G1 cyclin-dependent kinase inhibitors p21 and p16 also play critical roles in limiting rereplication. Hence, p53 and pRb are required during G1 to prevent entry into a replicative cycle and appear to provide a connection between the structural integrity of the microtubules and the cell cycle machinery in interphase cells.

摘要

细胞周期检查点是一种保障机制,可确保只有在上游过程完成后才启动下游事件。肿瘤抑制因子p53和pRb可响应纺锤体抑制剂而阻止第二轮复制的启动,但这是否为有丝分裂检查点反应尚未得到证实。我们发现,用诺考达唑处理后,异步培养的人成纤维细胞会停滞在G1期,DNA含量为4N,而同源的p53和pRb缺陷型成纤维细胞则会重新复制。重要的是,诺考达唑可使G0-G1期同步化的正常人成纤维细胞发生可逆性停滞,但对同源的p53缺陷型衍生物则无此作用。此外,G1期细胞周期蛋白依赖性激酶抑制剂p21和p16在限制重新复制方面也起着关键作用。因此,在G1期需要p53和pRb来防止进入复制周期,并且似乎在间期细胞中提供了微管的结构完整性与细胞周期机制之间的联系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验